Metraipolis › archive › dc_aaef8bd73ed5

Sustained response to minimal-dose tagraxofusp in a patient with BPDCN and advanced chronic kidney disease — Europe PMC PMID:41535617

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41535617
DOI: 10.1007/s00277-[numero omesso]-8
License (as archived): solo-consultazione
Archived: 2026-11-06T19:20:16.870Z
SHA-256 of the archived text: 8d0a0e833648b03ac07ebcc39bfa4c12837d026a897fb6a4341e4b7b80b0e748
Stable URL of this page: https://metraipolis.com/documento/dc_aaef8bd73ed5

How to cite

Sustained response to minimal-dose tagraxofusp in a patient with BPDCN and advanced chronic kidney disease — Europe PMC PMID:41535617 — Europe PMC (en), https://europepmc.org/article/MED/41535617 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aaef8bd73ed5 (Metraipolis archive dc_aaef8bd73ed5, sha256 8d0a0e833648b03ac07ebcc39bfa4c12837d026a897fb6a4341e4b7b80b0e748)

BibTeX

@misc{dcaaef8bd73ed5,
  title = {Sustained response to minimal-dose tagraxofusp in a patient with BPDCN and advanced chronic kidney disease — Europe PMC PMID:41535617},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41535617},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aaef8bd73ed5; sha256 8d0a0e833648b03ac07ebcc39bfa4c12837d026a897fb6a4341e4b7b80b0e748},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41535617. Agents can read the archived copy with the MCP tool read_document.